# Ondansetron

NDC: 55154-2876
Generic name: Ondansetron
Labeler / Manufacturer: Cardinal Health 107, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20061226

FDA application: ANDA077541

## Active ingredients

- ONDANSETRON HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55154-2876"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55154-2876
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee1f115f-c8f8-4526-b827-c8e48aeb5050